Chemical Communications · 2015 · 54 citations · 36 references
PharmacyPharmaceutical AnalysisPharmaceuticsBiopharmaceuticsBiophotonicsDrug DeliveryDrug Delivery SystemsDrug Release KineticsDrug Safety MonitoringFluorescence SpectroscopyIn Vitro PharmacologyIn Vitro-in Vivo CorrelationDrug Release MechanismsInfrared Spectroscopic MonitoringNear-infrared EmissionNear-infrared Fluorescence ImagingReal-time MonitoringRelease Profile Characterization
We developed a real-time drug-reporting conjugate (CPT-SS-CyN) composed of a near-infrared (NIR) fluorescent cyanine-amine dye (CyN), a disulfide linker, and a model therapeutic drug (camptothecin, CPT). Treatment with dithiothreitol (DTT) induces cleavage of the disulfide bond, followed by two simultaneous intramolecular cyclization reactions with identical kinetics, one to cleave the urethane linkage to release the NIR dye and the other to cleave the carbonate linkage to release CPT. The released CyN has an emission wavelength (760 nm) that is significantly different from CPT-SS-CyN (820 nm), enabling easy detection and monitoring of drug release. A linear relationship between the NIR fluorescence intensity at 760 nm and the amount of CPT released was observed, substantiating the use of this drug-reporting conjugate to enable precise, real-time, and non-invasive quantitative monitoring of drug release in live cells and semi-quantitative monitoring in live animals.
36
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
Ralph Weissleder, Ching‐Hsuan Tung, Umar Mahmood et al. · Nature Biotechnology · 1999 · 1.6K citations
Design considerations for tumour-targeted nanoparticles
Hak Soo Choi, Wenhao Liu, Fangbing Liu et al. · Nature Nanotechnology · 2009 · 745 citations